Certain agents (liraglutide, semaglutide, dulaglutide) reduce major cardiovascular events such as heart attack and stroke in high-risk patients
That typically results in worsening insulin resistance
02.Clinical Significance: Metabolic disorders during the recovery phase of myocardial infarction can weaken the body's resistance and slow the recovery process
If confirmed, this represents a new diabetes diagnosis that requires discussion with your provider about treatment modifications, monitoring frequency, and potential need for additional therapies beyond GLP-1 medication
Chronic Weight Management: Indicated for adults with a Body Mass Index (BMI) of 30 kg/m or greater (obesity), or 27 kg/m or greater (overweight) in the presence of at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia